Switzerland Israel city Tel Aviv virus covid-19 vaccine infection Switzerland Israel city Tel Aviv

TAU and Neovii team up to develop Covid-19 vaccine

Reading now: 510
www.pharmaceutical-technology.com

Israel-based Tel Aviv University (TAU)’s technology transfer company Ramot has entered a research and licence agreement with Swiss-based biopharmaceutical company Neovii to develop a vaccine against Covid-19.

As part of the alliance, Neovii will collaborate with a research team led by TAU’s School of Molecular Cell Biology and Biotechnology professor Jonathan Gershoni.

The deal provides the Swiss company with the exclusive right to develop and commercialise a platform technology created by Gershoni to rapidly identify epitope-based vaccines.

TAU and Neovii aim to develop a Covid-19 vaccine that could reconstruct the coronavirus’ receptor binding motif (RBM), an important structure of ‘spike’ protein of the virus.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA